1-3 of 3
A. Duncan
Close
Sort by
Journal Articles

Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

Marcela A. Ferrada, Sinisa Savic, Daniela Ospina Cardona, Jason C. Collins, Hugh Alessi, Fernanda Gutierrez-Rodrigues, Dinesh Babu Uthaya Kumar, Lorena Wilson, Wendy Goodspeed, James S. Topilow, Julie J. Paik, James A. Poulter, Tanaz A. Kermani, Matthew J. Koster, Kenneth J. Warrington, Catherine Cargo, Rachel S. Tattersall, Christopher J. A. Duncan, Anna Cantor, Patrycja Hoffmann, Elspeth M. Payne, Hanna Bonnekoh, Karoline Krause, Edward W. Cowen, Katherine R. Calvo, Bhavisha A. Patel, Amanda K. Ombrello, Daniel L. Kastner, Neal S. Young, Achim Werner, Peter C. Grayson, David B. Beck
Journal: Blood
Blood (2022) 140 (13): 1496–1506.
https://doi.org/10.1182/blood.2022016985
Published: 2022
Includes: Supplemental data
Journal Articles

Development & Validation of Hemophilia Treatment Regimen Specific Adherence Scales.

Natalie A. Duncan, MPH, Amy D. Shapiro, MD, Jennifer A. Maahs, PNP, Christopher P. Roberson, BS
Journal: Blood
Blood (2007) 110 (11): 966.
https://doi.org/10.1182/blood.V110.11.966.966
Published: 2007
Journal Articles

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

C. Shustik, R. Turner, P. Desjardins, L. Fernandez, S. Rubin, L. Larratt, A. Duncan, D. Rizi, A. Sadura, L. Shepherd, D. Li, L. Rassenti, T. Kipps
Journal: Blood
Blood (2005) 106 (11): 2977.
https://doi.org/10.1182/blood.V106.11.2977.2977
Published: 2005